Sign in
TerminatedNo phase

Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and

Key facts

Who runs it
Third People's Hospital, Huzhou City, Zhejiang Province, China
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
78 people enrolled
Started
13 Oct 2023
Ended
19 Sept 2024
Type of study
Interventional, 2 groups
Treatments tested
  • the conventional treatment group
  • the ACT group
Record updated
24 June 2025
Why it stopped
the sponsor has determined that access to the full dataset is no longer available

Who can take part

Age
60 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • (1)Meets the diagnostic criteria for schizophrenia as defined in the International Classification of Diseases, Tenth Revision (ICD-10)
  • (2) age > 60 years
  • (3)possesses at least a primary school education, enabling independent completion of all questionnaires
  • (4) has been taking antipsychotic medication continuously and regularly for at least one year during the enrollment period, with current symptoms and disease status stabilized in the maintenance phase
  • (5)informed consent obtained from the patient or their family/guardian

Who cannot take part

  • (4) receipt of electroconvulsive therapy within the past three months
  • (1) Coexisting organic mental disorders, affective disorders, or similar conditions
  • (2) coexisting physical illnesses that may affect cognitive function, such as hepatic or renal dysfunction
  • (3) alcohol dependence or dependence on psychoactive substances

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

ACT combined with stratified intervention improved cognitive function and quality of life in elderly schizophrenia patients by enhancing psychological flexibility and family support.

The 2 groups in the trial

  • the conventional treatment groupOther group

    Patients received conventional mental health education once weekly for 6 weeks, covering schizophrenia symptoms, treatment, and prognosis. Standard nursing care and antipsychotic medications (e.g., olanzapine, quetiapine) were maintained without additional psychological interventions.

  • the ACT groupOther group

    Patients received ACT-based nursing interventions tailored to risk factors (e.g., age ≥70, long disease duration), including: ACT modules: Acceptance, cognitive defusion, mindfulness, values clarification, and committed action. Adjunct strategies: Family therapy, Tai Chi, and crisis planning. Frequency: Daily practice + 1-2 group sessions/week for 6 weeks. Goal: Enhance psychological flexibility, reduce stigma, and improve cognitive function.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and the Application Effect of Acceptance and Commitment Therapy Nursing Model
Record updated
24 June 2025